Submitted by Anonymous (not verified) on 30 October 2023 - 14:02
Human medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Prostatic Neoplasms, Date of authorisation: 13/11/2013, Revision: 14, Status: Authorised
Source: